Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies
- PMID: 10361133
Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies
Abstract
Death-associated protein kinase (DAP-Kinase) is a novel serine/threonine kinase whose expression is required for gamma interferon-induced apoptosis. A previous study suggested that DAP-Kinase expression may be lost epigenetically in cancer cell lines, because treatment of several nonexpressing cell lines with 5-aza-2'-deoxycytidine resulted in the expression of DAP-Kinase. Using methylation-specific polymerase chain reaction (MSP), we examined the DAP-Kinase CpG island for hypermethylation in cancer. Normal lymphocytes and lymphoblastoid cell lines are unmethylated in the 5' CpG island of DAP-Kinase. However, in primary tumor samples, all Burkitt's lymphomas and 84% of the B-cell non-Hodgkin's lymphomas were hypermethylated in the DAP-Kinase CpG island. In contrast, none of the T-cell non-Hodgkin's lymphoma samples and 15% or less of leukemia samples examined had hypermethylated DAP-Kinase alleles. U937, an unmethylated, DAP-Kinase-expressing leukemia cell line, was treated with gamma interferon and underwent apoptosis; however, Raji, a fully methylated, DAP-Kinase nonexpressing Burkitt's lymphoma cell line, only did so when treated with 5-aza-2'-deoxycytidine followed by gamma interferon. Our findings in cell lines and primary tumors suggest that hypermethylation of the DAP-Kinase gene and loss of gamma interferon-mediated apoptosis may be important in the development of B-cell malignancies and may provide a promising biomarker for B-cell-lineage lymphomas.
Comment in
-
DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?Blood. 2000 May 1;95(9):2997-9. Blood. 2000. PMID: 10841615 No abstract available.
Similar articles
-
Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies.Cancer Sci. 2003 Jan;94(1):87-91. doi: 10.1111/j.1349-7006.2003.tb01357.x. Cancer Sci. 2003. PMID: 12708480 Free PMC article.
-
Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.Med Pediatr Oncol. 2003 Dec;41(6):527-31. doi: 10.1002/mpo.10326. Med Pediatr Oncol. 2003. PMID: 14595709
-
[Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].Rinsho Byori. 2001 Dec;49(12):1242-7. Rinsho Byori. 2001. PMID: 11797395 Review. Japanese.
-
Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.Vet Immunol Immunopathol. 2014 Oct 15;161(3-4):222-31. doi: 10.1016/j.vetimm.2014.08.011. Epub 2014 Aug 23. Vet Immunol Immunopathol. 2014. PMID: 25193469
-
Death associated protein kinase: from regulation of apoptosis to tumor suppressive functions and B cell malignancies.Apoptosis. 2002 Jun;7(3):261-70. doi: 10.1023/a:1015364104672. Apoptosis. 2002. PMID: 11997670 Review.
Cited by
-
Hypermethylation status of DAPK, MGMT and RUNX3 in HPV negative oral and oropharyngeal squamous cell carcinoma.Genet Mol Biol. 2020 Aug 21;43(3):e20190334. doi: 10.1590/1678-4685-gmb-2019-0334. Genet Mol Biol. 2020. PMID: 32870234 Free PMC article.
-
Epigenetic Determinants of Cancer.Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a019505. doi: 10.1101/cshperspect.a019505. Cold Spring Harb Perspect Biol. 2016. PMID: 27194046 Free PMC article. Review.
-
Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma.Int J Hematol. 2006 May;83(4):341-7. doi: 10.1532/IJH97.05182. Int J Hematol. 2006. PMID: 16757436
-
Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma.Pathol Oncol Res. 2004;10(1):17-21. doi: 10.1007/BF02893403. Epub 2004 Mar 18. Pathol Oncol Res. 2004. PMID: 15029256
-
Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.Int J Hematol. 2004 Aug;80(2):120-7. doi: 10.1532/ijh97.04075. Int J Hematol. 2004. PMID: 15481439 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials